These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29430115)

  • 1. 18F-Fluorodeoxyglucose Positron Emission Tomography-computed Tomography in Evaluation of Large Vessel Vasculitis.
    Rayudu AL; Kalawat T; Krishna Mohan VS; Mohan A; Lakshmi AY; Mantri RG
    Indian J Nucl Med; 2018; 33(1):48-51. PubMed ID: 29430115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [18F-FDG PET in the diagnosis of large vessel vasculitis].
    Rehák Z; Fojtík Z; Stanícek J; Bolcák K; Frysáková L
    Vnitr Lek; 2006 Nov; 52(11):1037-44. PubMed ID: 17165522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of 18F-FDG PET or PET/CT for large vessel vasculitis : A meta-analysis.
    Lee YH; Choi SJ; Ji JD; Song GG
    Z Rheumatol; 2016 Nov; 75(9):924-931. PubMed ID: 26704559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lesson of the month 1: Large vessel vasculitis - a diagnostic challenge and the role of 18-fluorodeoxyglucose positron emission tomography.
    Allard A; Mootoo R
    Clin Med (Lond); 2017 Jul; 17(4):369-370. PubMed ID: 28765420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of fluorine-18-fluorodeoxyglucose positron emission tomography in the diagnosis and monitoring of large vessel vasculitis: A South Australian retrospective audit.
    Nguyen AD; Crowhurst T; Lester S; Dobson R; Bartholomeusz D; Hill C
    Int J Rheum Dis; 2019 Aug; 22(8):1378-1382. PubMed ID: 31211510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of 18F Fluorodeoxyglucose Positron Emission Tomography Scanning in the Diagnosis and Management of Systemic Vasculitis.
    Danve A; O'Dell J
    Int J Rheum Dis; 2015 Sep; 18(7):714-24. PubMed ID: 26177990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of PET/CT imaging to differential diagnosis of fever of unknown origin.
    Halcin A; Kinova S
    Bratisl Lek Listy; 2013; 114(2):67-70. PubMed ID: 23331201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18-Fluorodeoxyglucose positron emission tomography/computed tomography for large vessel vasculitis in clinical practice.
    Nassarmadji K; Vanjak A; Bourdin V; Champion K; Burlacu R; Mouly S; Sène D; Comarmond C
    Front Med (Lausanne); 2023; 10():1103752. PubMed ID: 36744139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET/CT for Diagnosis and Management of Large-Vessel Vasculitis.
    Pelletier-Galarneau M; Ruddy TD
    Curr Cardiol Rep; 2019 Mar; 21(5):34. PubMed ID: 30887249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with Takayasu's arteritis having persistent acute-phase response usually have an increased major vessel uptake by 18F-FDG-PET/CT.
    Alibaz-Oner F; Dede F; Ones T; Turoglu HT; Direskeneli H
    Mod Rheumatol; 2015 Sep; 25(5):752-5. PubMed ID: 25671403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vasculitis assessment with [18F]FDG positron emission tomography].
    Liozon E; Monteil J; Ly KH; Vidal E
    Rev Med Interne; 2010 Jun; 31(6):417-27. PubMed ID: 20416990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy.
    Nielsen BD; Gormsen LC; Hansen IT; Keller KK; Therkildsen P; Hauge EM
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1119-1128. PubMed ID: 29671039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [(18)F]fluorodeoxyglucose PET in large vessel vasculitis.
    Walter MA
    Radiol Clin North Am; 2007 Jul; 45(4):735-44, viii. PubMed ID: 17706537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring Vasculitis with 18F-FDG PET.
    Bucerius J
    Q J Nucl Med Mol Imaging; 2016 Sep; 60(3):219-35. PubMed ID: 27280732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-body fluorodeoxyglucose positron emission tomography/computed tomography in patients with active polymyalgia rheumatica: evidence for distinctive bursitis and large-vessel vasculitis.
    Yamashita H; Kubota K; Takahashi Y; Minaminoto R; Morooka M; Ito K; Kano T; Kaneko H; Takashima H; Mimoiri A
    Mod Rheumatol; 2012 Sep; 22(5):705-11. PubMed ID: 22205118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-fluorodeoxyglucose positron emission tomography and the risk of subsequent aortic complications in giant-cell arteritis: A multicenter cohort of 130 patients.
    de Boysson H; Liozon E; Lambert M; Parienti JJ; Artigues N; Geffray L; Boutemy J; Ollivier Y; Maigné G; Ly K; Huglo D; Hachulla E; Hatron PY; Aouba A; Manrique A; Bienvenu B
    Medicine (Baltimore); 2016 Jun; 95(26):e3851. PubMed ID: 27367985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The application of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in inflammation and infectious disease].
    Yao Y; Ou X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2020 Aug; 37(4):730-735. PubMed ID: 32840092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for the Detection of Recurrent Disease after Treatment of Malignant Melanoma.
    Lee JW; Nam SB; Kim SJ
    Oncology; 2019; 97(5):286-293. PubMed ID: 31437839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (18)F-FDG PET/CT for the detection of large vessel vasculitis in patients with polymyalgia rheumatica.
    Lavado-Pérez C; Martínez-Rodríguez I; Martínez-Amador N; Banzo I; Quirce R; Jiménez-Bonilla J; De Arcocha-Torres M; Bravo-Ferrer Z; Jiménez-Alonso M; López-Defilló JL; Blanco R; González-Gay MA; Carril JM
    Rev Esp Med Nucl Imagen Mol; 2015; 34(5):275-81. PubMed ID: 26159505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy response evaluation in large-vessel vasculitis: a new role for [18F]FDG-PET/CT?
    Slart RHJA; Glaudemans AWJM; Brouwer E; van der Geest KSM
    Rheumatology (Oxford); 2021 Aug; 60(8):3494-3495. PubMed ID: 33909889
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.